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Our research interests are the molecular design and synthesis of 
 specifi c inhibitors of physiologically important enzymes (biocatalysts) 
for use as chemical probes to understand the reaction mechanisms, 
three-dimensional structures and physiological roles of the enzymes. 
The fi nely designed inhibitors are further elaborated to develop useful 
in vivo active biochemical reagents and the lead compounds for 
 pharmaceuticals and  agrochemicals. Our current research includes the 
design, synthesis and applications of transition-state analog and mech-
anism-based  inhibitors of the key enzymes in glutathione homeostasis, 
asparagine synthesis, and the acyl-activating enzyme superfamily that 
plays pivotal roles in plant hormone homeostasis, secondary metabo-
lite biosynthesis and β-oxidation of fatty acids. The synthesis and 
 evaluation of substrates and inhibitors of ABC transporters and the 
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Design, Synthesis and Applications of Specifi c 
Inhibitors of γ-Glutamylcysteine Synthetase 
and γ-Glutamyl Transpeptidase for 
Modulating Cellular Redox Status
Glutathione (GSH, γ-Glu-Cys-Gly) is an ubiquitous 
tripeptide found in many organisms, and plays central 
roles in the redox status of cells not only by detoxifi cation 
of reactive oxygen species, but also by regulating the 
transcription of specific genes such as phase II anti-
oxidant enzymes. We are interested in regulating the 
cellular GSH level that leads to the modulation of cellular 
redox status by controlling the activities of its biosynthetic 
enzyme, γ-glutamylcysteine synthetase (GCS), and its 
metabolic enzyme, γ-glutamyl transpeptidase (GGT), by 
using specifi c inhibitors (Figure 1). The compound 1, 
designed as a transition-state analog, was found to serve 
as a potent mechanism-based inhibitor of GCS. The X-ray 
crystal structure of E. coli GCS in complex with 1 (Figure 
2) revealed that the carboxy group (blue) as well as the 
side chain (magenta) is critical for the recognition by 
GCS, thereby the inhibition potency of 1 being 500-times 
higher than a classical GCS inhibitor, BSO, lacking the 
carboxy group. Furthermore, the introduction of a cyano 
group (compound 2) as a mimic of SH further increased 
the inhibition potency by 31 and 55 times for the E. coli
and the pathogenic Streptococcus agalactiae GCS, respec-
tively. Notably, the inhibition potency of 2 is signifi cantly 
higher (10,000 times) than BSO for the latter enzyme. The 
negatively charged carboxy group, however, appears to 
hinder the penetration of 1 and 2 through the cell mem-
brane. Therefore a series of dipeptide-based inhibitors 3
was prepared for active transport through bacterial peptide 
transporters. This aspect of study is now under way to 
develop novel pharmaceuticals to combat multi-drug 
resistant pathogenic bacteria.
In glutathione biosynthesis, another limiting factor is 
the availability of Cys. γ-Glutamyl transpeptidase (GGT)
is a key enzyme in supplying the cells with Cys by cleaving
the γ-glutamyl bond of GSH, as well as in degrading GSH
conjugates for detoxifi cation. We have developed a series
of phosphonate-based inactivators of GGT and found that 
a glutathione-like inhibitor 4 was highly efficient for 
human GGT. In light of the specifi c recognition of the
C-terminal carboxy group by human GGT, a simplifi ed 
peptide analog 5 was prepared and found to be a highly
potent inactivator of human GGT. The inhibitor 5 was
specifi c for GGT, non-toxic and rather stable compound,
serving as a useful biochemical reagent to knock down
GGT in vivo. Interestingly, compound 5 significantly
increased the biosynthesis of collagen I of human skin
fi broblasts and can be used, for example, as a novel anti-
aging cosmetic ingredient.
Figure 1. Biosynthesis, reaction and metabolism of glutathione (GSH) in 
cell. The specifi c inhibitors of GCS and GGT are shown (red squares).
Figure 2. X-Ray crystal structure of the Cys binding site of E. coli GCS
in complex with 1.
